PA

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.2M
Cap. Flow %
-1.95%
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3 years
Top 10 Avg Time Held Equity + Options
2.4 years
Top 20 Avg Time Held Equity + Options
2.4 years
Avg Time Held Equity only
3 years
Top 10 Avg Time Held Equity only
2.4 years
Top 20 Avg Time Held Equity only
2.4 years

Top Buys

Rank Stock Value
1
FALN icon
iShares Fallen Angels USD Bond ETF
FALN
+$9.31M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$6.87M
3
EFTR icon
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$3.6M
4
CORT icon
Corcept Therapeutics
CORT
+$3M
5
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$2.68M

Top Sells

Rank Stock Value
1
ESGV icon
Vanguard ESG US Stock ETF
ESGV
+$9.63M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$7.01M
3
MSFT icon
Microsoft
MSFT
+$5.41M
4
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$5.16M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.44M

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.1%
2 Technology 15.39%
3 Financials 8.2%
4 Healthcare 7.16%
5 Consumer Discretionary 5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CMCSA icon
126
Comcast
CMCSA
$74.7B
$2.88M 0.11%
60,415
+2,508
+4% +$121K
2016 Q4
21 quarters
RCUS icon
127
Arcus Biosciences
RCUS
$2.87B
$2.83M 0.11%
84,828
+25
+0% +$838
2019 Q2
11 quarters
SNOW icon
128
Snowflake
SNOW
$118B
$2.79M 0.11%
12,041
-4,813
-29% -$1.24M
2020 Q3
6 quarters
AMT icon
129
American Tower
AMT
$83.6B
$2.76M 0.11%
11,016
+237
+2% +$57.8K
2016 Q4
21 quarters
EFTR icon
130
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2.74M 0.11%
+27,098
New +$3.6M
2022 Q1
0 quarters
HDV icon
131
iShares Core High Dividend ETF
HDV
$15.3B
$2.72M 0.11%
125,940
+1,470
+1% +$30.5K
2016 Q4
21 quarters
VTIP icon
132
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.6B
$2.7M 0.11%
52,599
+13,939
+36% +$715K
2016 Q4
21 quarters
LYFT icon
133
Lyft
LYFT
$6.24B
$2.7M 0.11%
69,859
+109
+0.2% +$4.27K
2019 Q2
11 quarters
BRK.A icon
134
Berkshire Hathaway Class A
BRK.A
$1.13T
$2.68M 0.11%
5
– –
2016 Q4
21 quarters
CVS icon
135
CVS Health
CVS
$116B
$2.67M 0.11%
25,757
-14,961
-37% -$1.57M
2016 Q4
21 quarters
SBUX icon
136
Starbucks
SBUX
$106B
$2.62M 0.1%
28,764
-1,877
-6% -$177K
2016 Q4
21 quarters
MGC icon
137
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
$2.6M 0.1%
16,116
-3,646
-18% -$572K
2016 Q4
21 quarters
TSM icon
138
TSMC
TSM
$2.23T
$2.58M 0.1%
24,145
-3,319
-12% -$388K
2016 Q4
21 quarters
LQD icon
139
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.2B
$2.57M 0.1%
21,167
-4,148
-16% -$517K
2016 Q4
21 quarters
MCD icon
140
McDonald's
MCD
$169B
$2.55M 0.1%
10,229
-1,030
-9% -$257K
2016 Q4
21 quarters
HON icon
141
Honeywell
HON
$65.8B
$2.52M 0.1%
13,614
+663
+5% +$123K
2016 Q4
21 quarters
ARKK icon
142
ARK Innovation ETF
ARKK
$8.79B
$2.5M 0.1%
36,401
-991
-3% -$69.9K
2018 Q1
16 quarters
ADI icon
143
Analog Devices
ADI
$196B
$2.48M 0.1%
14,908
+7,424
+99% +$1.2M
2016 Q4
21 quarters
VT icon
144
Vanguard Total World Stock ETF
VT
$81.7B
$2.46M 0.1%
23,897
+100
+0.4% +$10.1K
2016 Q4
21 quarters
BND icon
145
Vanguard Total Bond Market
BND
$162B
$2.44M 0.1%
30,676
-33,631
-52% -$2.75M
2016 Q4
21 quarters
AVGO icon
146
Broadcom
AVGO
$1.65T
$2.4M 0.1%
38,080
-570
-1% -$33.9K
2016 Q4
21 quarters
TGT icon
147
Target
TGT
$70.6B
$2.39M 0.09%
10,775
+530
+5% +$115K
2016 Q4
21 quarters
IVW icon
148
iShares S&P 500 Growth ETF
IVW
$78.3B
$2.34M 0.09%
30,067
+3,434
+13% +$258K
2016 Q4
21 quarters
VCSH icon
149
Vanguard Short-Term Corporate Bond ETF
VCSH
$43.9B
$2.33M 0.09%
29,910
-3,469
-10% -$276K
2016 Q4
21 quarters
FCX icon
150
Freeport-McMoran
FCX
$100B
$2.33M 0.09%
45,956
-1,149
-2% -$50.9K
2016 Q4
21 quarters
4 5
6
7 8

Similar funds

AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $6.51B AUM 25.32% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.